Apa Dampak Pemeriksaan Patologis Mikroskopis pada Prognosis Kanker? : Tinjauan Sistematis
Keywords:
Kanker, Prognosis, Patologi Mikroskopis, Biomarker, Invasi LimfovaskularAbstract
Pendahuluan: Kanker merupakan penyebab utama kematian secara global, dengan prognosis yang sangat bervariasi bergantung pada karakteristik biologis dan patologis tumor. Pemeriksaan patologis mikroskopis berperan sentral dalam menentukan prognosis kanker, memberikan informasi mendetail mengenai fitur tumor seperti invasi limfovaskular, margin bedah positif, dan metastasis nodal. Penelitian ini bertujuan untuk mengkaji dampak komprehensif pemeriksaan patologis mikroskopis terhadap prognosis kanker, berfokus pada fitur tradisional dan biomarker baru.
Metode: Tinjauan sistematis ini mengikuti pedoman Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 untuk memastikan ketelitian metodologis. Strategi pencarian menggunakan kata kunci berdasarkan PICO (Population: Cancer Patients, Intervention: Microscopic Pathology, Comparison: Traditional Markers, Outcome: Cancer Prognosis) pada basis data seperti PubMed, Semantic Scholar, Springer, dan Google Scholar. Sebanyak 40 studi memenuhi kriteria inklusi setelah penyaringan dan penilaian kualitas.
Hasil: Studi-studi yang disertakan mencakup berbagai jenis kanker padat, dengan kanker prostat menjadi yang paling sering diteliti. Fitur patologis tradisional seperti invasi limfovaskular, margin bedah positif, dan metastasis nodus limfa secara konsisten berhubungan dengan prognosis yang buruk. Rasio hazard untuk luaran yang merugikan berkisar antara 1,37 hingga 6,94. Biomarker baru seperti Imunoscore dan patologi digital berbasis kecerdasan buatan menunjukkan potensi untuk menyempurnakan stratifikasi risiko.
Diskusi: Pemeriksaan patologis mikroskopis, baik tradisional maupun inovatif, sangat penting dalam prognostikasi kanker pada tumor padat. Fitur tradisional secara konsisten dikaitkan dengan luaran yang merugikan , sementara biomarker baru dan alat patologi digital dapat menyempurnakan model prognostik, meskipun nilai tambahnya bervariasi tergantung konteks. Tantangan utama meliputi standarisasi metodologi dan integrasi penanda baru ke dalam praktik klinis.
Kesimpulan: Fitur patologis mikroskopis adalah inti dari prognostikasi kanker pada tumor padat, dengan penanda tradisional yang secara konsisten memprediksi luaran yang merugikan dan biomarker baru yang berpotensi menyempurnakan model prognostik. Integrasi temuan patologis ini ke dalam sistem penentuan stadium dan pengambilan keputusan klinis sangat memperkuat peran sentral mereka dalam memprediksi luaran kanker.
References
A. Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, J. Simko, S. DeVries, E. Chen, et al. “Prostate Cancer Therapy Personalization via Multi-Modal Deep Learning on Randomized Phase III Clinical Trials.” Npj Digital Medicine, 2022.
B. Guani, Katia Mahiou, Adrien Crestani, D. Cibula, Alessandro Buda, Thomas Gaillard, Patrice Mathevett, et al. “Clinical Impact of Low-Volume Lymph Node Metastases in Early-Stage Cervical Cancer: A Comprehensive Meta-Analysis.” Social Science Research Network, 2021.
B. Guani, Katia Mahiou, Adrien Crestani, Fabrice Lécuru, Patrice Mathevett, and V. Balaya. “Clinical Impact of Low-Volume Lymph Node Metastases in Early-Stage Cervical Cancer: A Comprehensive Meta-Analysis (504).” Gynecologic Oncology, 2022.
C. Crockett, and R. Simões. "OncoFlash - Research Updates in a Flash! (June 2023 Edition).” Clinics in Oncology, 2023.
C. Welty, J. Cowan, Hao G Nguyen, K. Shinohara, Nannette Perez, Kirsten L. Greene, J. Chan, et al. "Extended Followup and Risk Factors for Disease Reclassification in a Large Active Surveillance Cohort for Localized Prostate Cancer.” Journal of Urology, 2015.
Daniel P. McCarthy, and M. Decamp. “Does the Punishment Fit the Crime?: Using Frozen Section Results to Guide Extent of Resection.” Chest, 2021.
Eder da Silva Dolens, M. R. Dourado, A. Almangush, T. Salo, C. A. Gurgel Rocha, S. D. da Silva, P. Brennan, and R. Coletta. “The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis.” Frontiers in Oncology, 2021.
G. Sharma, A. Yadav, Tarun Pareek, P. Kaundal, S. Tyagi, S. Devana, and S. Singh. “Impact of Pathological Factors on Survival in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.” International Brazilian Journal of Urology, 2021.
Hai Huang, Xiu-Wu Pan, Yi Huang, Danfeng Xu, X. Cui, Lin Li, Yi Hong, Lu Chen, Yi Gao, and L. Yin. “Microvascular Invasion as a Prognostic Indicator in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.” International Journal of Clinical and Experimental Medicine, 2015.
Haoran Liu, Hui Zhou, Libin Yan, T. Ye, Hongyan Lu, Xifeng Sun, Z. Ye, and Hua Xu. “Prognostic Significance of Six Clinicopathological Features for Biochemical Recurrence After Radical Prostatectomy: A Systematic Review and Meta-Analysis.” OncoTarget, 2015.
Hong Guo, Lei Zhang, Y. Shao, Kunyang An, Caoyang Hu, Xuezhi Liang, and Dongwen Wang. “The Impact of Positive Surgical Margin Parameters and Pathological Stage on Biochemical Recurrence After Radical Prostatectomy: A Systematic Review and Meta-Analysis.” medRxiv, 2024.
Ihsane El Otmani, Fatima El Agy, Mohammed El Abkari, K. I. M. Hassani, K. Mazaz, E. Benjelloum, K. A. Taleb, et al. “The Effect of Lymph Nodes’ Histologic Response on Survival Outcomes in Moroccan Patients with Rectal Cancer.” International Journal of Surgical Oncology, 2020.
J. Padayao, and C. Dy. "P-392 The Prognostic Ability of ImmunoScore in Predicting Outcomes in Patients with Localized Colon Cancer: A Systematic Review and Meta-Analysis.” Annals of Oncology, 2023.
J. Padayao, and C. Dy. "The Prognostic Ability of Immune Scoring System ImmunoScore in Patients with Localized Colon Cancer: A Systematic Review and Meta-Analysis.” Journal of Clinical Oncology, 2023.
Jinbin Xu, Yiyuan Tan, Shuntian Gao, Weijen Lee, Yuedian Ye, Gengguo Deng, Zhansen Huang, et al. “Microvascular Invasion Is Associated with Poor Prognosis in Renal Cell Carcinoma: A Retrospective Cohort Study and Meta-Analysis.” Frontiers in Oncology, 2024.
Jonathan B Bloom, Graham Hale, Samuel Gold, K. Rayn, Clayton P. Smith, Sherif Mehralivand, M. Czarniecki, et al. “Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.” Journal of Urology, 2018.
K. Mori, F. Janisch, M. K. Parizi, H. Mostafaei, I. Lysenko, S. Kimura, D. Enikeev, S. Egawa, and S. Shariat. “Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.” Journal of Urology, 2020.
Lijin Zhang, Bin Wu, Z. Zha, Hu Zhao, and Yejun Feng. “The Clinical Prognostic Value of Microvascular Invasion in Non-Metastatic Renal Cell Cancer Following Surgical Resection: A Systematic Review and Meta-Analysis,” 2018.
Lisa F. Newcomb, L. Thompson, Hillary D. Boyer, J. Brooks, P. Carroll, M. Cooperberg, Atreya Dash, et al. “Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.” Journal of Urology, 2016.
M. Di Bartolomeo, F. Morano, A. Raimondi, R. Miceli, S. Corallo, E. Tamborini, F. Perrone, et al. “Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.” The Oncologist, 2019.
M. Moschini, Vidit Sharma, F. Zattoni, S. Boorjian, I. Frank, M. Gettman, R. Thompson, M. Tollefson, E. Kwon, and R. Karnes. “Risk Stratification of pN+ Prostate Cancer After Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup.” Journal of Urology, 2016.
M. R. Dourado, E. Guerra, T. Salo, D. Lambert, and R. Coletta. “Prognostic Value of the Immunohistochemical Detection of Cancer-associated Fibroblasts in Oral Cancer: A Systematic Review and Meta-analysis.” Journal of Oral Pathology & Medicine, 2018.
Melek Hüyük, M. Fioccop, M. Postmus, D. Cohen, and J. H. von der Thüsen. “Systematic Review and Meta-analysis of the Prognostic Impact of Lymph Node Micrometastasis and Isolated Tumour Cells in Patients with Stage I-IIIA Non-small Cell Lung Cancer.” Histopathology, 2022.
N. Brouwer, and L. Nagtegaal. “Tumor Deposits Improve Staging in Colon Cancer: What Are the Next Steps?” Annals of Oncology, 2021.
N. Miura, K. Mori, H. Mostafaei, F. Quhal, R. Motlagh, B. Pradère, E. Laukhntina, D. D’Andrea, T. Saika, and S. Shariat. “The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis.” Journal of Urology, 2020.
P. Tajarernmuang, L. Ohara, Stéphane Beaudoin, Hangjun Wang, A. Benedetti, and Anne V Gonzalez. “Real-World Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Treated with Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA Vs. Histological Specimens.” Chest, 2021.
Pooya Mobadersany, S. Tian, S. Yip, J. Greshock, Najat Khan, Margaret K Yu, S. McCarthy, et al. “AI-Enabled Analysis of H&E-Stained Prostate Cancer Tissue Images: Assessing Risk for Metastasis prior to Apalutamide (APA) Treatment of Patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC).” Journal of Clinical Oncology, 2023.
R. Dess. “Personalized Medicine in Localized Prostate Cancer: Are We There Yet?” International Journal of Radiation Oncology, Biology, Physics, 2022.
R. Dess, Y. Sun, M. Bolla, A. Zapatero, S. Malone, A. U. Kishan, S. Roy, et al. “Prognostic and Predictive Performance of Routine Clinicopathologic Variables in 10,535 Men Enrolled on Randomized Phase III Trials in Localized Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics, 2021.
R. Osarogiagbon. “The Pathologic Nodal Staging Quality Gap: Challenge as Opportunity in Disguise.” Journal of Thoracic Oncology, 2022.
R. Osarogiagbon, M. Ray, C. Feihnel, O. Akinbobola, A. Saulsberry, K. Dortch, N. Faris, Anberitha T Matthews, M. Smeltzer, and D. Spencer. “Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.” Annals of Thoracic Surgery, 2023.
R. Osarogiagbon, M. Smeltzer, N. Faris, R. Rami-Porta, P. Goldstraw, and H. Asamura. “Comment on the Proposals for the Revision of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.” Journal of Thoracic Oncology, 2016.
S. Kamarajah, E. Marson, Dengyi Zhou, Freddie Wyn-Griffiths, A. Lin, R. Evans, J. Bundred, Pritam Singh, and E. Griffiths. “Meta-Analysis of Prognostic Factors of Overall Survival in Patients Undergoing Oesophagectomy for Oesophageal Cancer.” Diseases of the Esophagus, 2019.
T. Diker-Cohen, D. Harel, I. Maimon, G. Hadas, A. Akriv, Hadar Tuskin-Bitan, and E. Robenshtok. “Impact of Minimal Extrathyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-Analysis.” Journal of Clinical Endocrinology and Metabolism, 2018.
T. Frye, A. George, A. Kilchevsky, M. Maruf, M. Siddiqui, M. Kongyuyh, A. Muthigi, et al. “Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer.” Journal of Urology, 2017.
V. Goh, S. Mallett, M. Rodriguez-Justo, Victor Boulter, R. Glynne-Jones, Saif Khan, Sarah Lessels, et al. “Evaluation of Prognostic Models to Improve Prediction of Metastasis in Patients Following Potentially Curative Treatment for Primary Colorectal Cancer: The PROSPECT Trial.” Health Technology Assessment, 2025.
Wei Jiang, Lijin Zhang, Bin Wu, Z. Zha, Hu Zhao, Yuan Jun, and Yuefang Jiang. “The Impact of Lymphovascular Invasion in Patients with Prostate Cancer Following Radical Prostatectomy and Its Association with Their Clinicopathological Features.” Medicine, 2018.
Weidong Li, Yun-wei Han, Chijuan Wang, Xiaojing Guo, Beibei Shen, Fangfang Liu, Chengying Jiang, et al. “Precise Pathologic Diagnosis and Individualized Treatment Improve the Outcomes of Invasive Micropapillary Carcinoma of the Breast: A 12-Year Prospective Clinical Study.” Modern Pathology, 2018.
Yong-Ji Zeng, Chunting Zhang, and D. Dai. “Impact of Lymph Node Micrometastasis on Gastric Carcinoma Prognosis: A Meta-Analysis.” World Journal of Gastroenterology, 2015.
Zhiyuan Jiang, Z. Cai, Yuan Yin, Chao-yong Shen, Jinming Huang, Yi-qiong Yin, and Bo Zhang. “Impact of Surgical Margin Status on the Survival Outcome After Surgical Resection of Gastric Cancer: A Protocol for Systematic Review and Meta-Analysis.” BMJ Open, 2020.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Fidi Kusuma, Rosita (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
